A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
Status:
Completed
Trial end date:
2018-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the activity of romidepsin in patients with
progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with
systemic therapy.